Efficacy and Adverse Effect of Simvastatin Compare to Rosuvastatin in Systemic Lupus Erythematosus (SLE) Patients With Corticosteroid Therapy and High Low-Density Lipoprotein (LDL) Cholesterol Level

PHASE4UnknownINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

March 31, 2010

Study Completion Date

June 30, 2010

Conditions
Systemic Lupus ErythematosusHigh LDL Cholesterol Level
Interventions
DRUG

Rosuvastatin

10 mg per day for 12 weeks

DRUG

Simvastatin

20 mg per day

Trial Locations (1)

10240

RECRUITING

Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Ramathibodi Hospital

OTHER